LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 1235 | 619 | 4277 | 0.1447 | -0.3203 |
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 1235 | 631 | 4583 | 0.1377 | -0.2992 |
MDA-MB-231 | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 1235 | 372 | 4355 | 0.0854 | -0.4835 |
MDA-MB-231 | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 1235 | 374 | 4277 | 0.0874 | -0.4870 |
MDA-MB-231 | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 1235 | 337 | 4583 | 0.0735 | -0.4971 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 1235 | 4610 | 4474 | 1.0302 | 1.0324 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 1235 | 4495 | 4578 | 0.9818 | 0.9806 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 1235 | 5206 | 4929 | 1.0561 | 1.0555 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 1235 | 4200 | 4474 | 0.9386 | 0.9329 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 1235 | 4667 | 4578 | 1.0193 | 1.0204 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 1235 | 4730 | 4929 | 0.9596 | 0.9591 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 1235 | 4109 | 4474 | 0.9183 | 0.9102 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 1235 | 4019 | 4578 | 0.8778 | 0.8667 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 1235 | 4531 | 4929 | 0.9192 | 0.9173 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 1235 | 2922 | 4474 | 0.6530 | 0.5897 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 1235 | 2969 | 4578 | 0.6485 | 0.5902 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 1235 | 3523 | 4929 | 0.7147 | 0.6902 |
MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 1235 | 1426 | 4474 | 0.3187 | 0.0801 |
MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 1235 | 1533 | 4578 | 0.3348 | 0.1208 |
MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 1235 | 1784 | 4929 | 0.3619 | 0.2019 |
MDA-MB-231 | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 1235 | 779 | 4474 | 0.1741 | -0.2202 |
MDA-MB-231 | Pelitinib | 10 | uM | LJP5 | 2 | I13 | 72 | hr | 1235 | 742 | 4578 | 0.1621 | -0.2367 |
MDA-MB-231 | Pelitinib | 10 | uM | LJP5 | 3 | I13 | 72 | hr | 1235 | 748 | 4929 | 0.1518 | -0.2225 |
MDA-MB-231 | Luminespib | 0.04 | uM | LJP5 | 1 | H18 | 72 | hr | 1235 | 764 | 4474 | 0.1707 | -0.2283 |
MDA-MB-231 | Luminespib | 0.04 | uM | LJP5 | 2 | H18 | 72 | hr | 1235 | 910 | 4578 | 0.1988 | -0.1496 |